Interleukin 2

• EARLY_PHASE1RECRUITING
  Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · NCT06920199
• NAWITHDRAWN
  A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)National Institute of Allergy and Infectious Diseases (NIAID) · NCT00000804
• NACOMPLETED
  A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected PatientsNational Institute of Allergy and Infectious Diseases (NIAID) · NCT00001116
• PHASE3COMPLETED
  Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's LymphomaNational Cancer Institute (NCI) · NCT00002649
• PHASE3COMPLETED
  A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3National Institute of Allergy and Infectious Diseases (NIAID) · NCT00000949
• PHASE2COMPLETED
  Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute LeukemiaHerbert Irving Comprehensive Cancer Center · NCT00008190

via ClinicalTrials.gov

Wikidata facts

Image

IL2 Crystal Structure.png

via Wikidata · CC0